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Abstract: There were two objectives set for this research project. The first objective of 
this experiment was to determine potential competitive inhibition between different 
strains of Bacillus spp. and pathogenic bacteria. The experiment was designed to observe 
how effectively a probiotic (Bacillus spp.) might inhibit the growth of a pathogenic 
species. Probiotics are microorganisms that possess no pathogenic characteristics or 
effects, and can potentially be utilized to inhibit the growth of microbial pathogenic 
species while also boosting metabolism of the host. The method used in the experiment 
was well diffusion. Pathogen species Salmonella enterica serovar Muenchen (SE) and 
Shiga Toxin Producing Escherichia coli were isolated, cultivated and then used to 
inoculate individual Tryptic Soy Agar (TSA) media. After the pathogenic TSA had been 
incubated, they were immediately poured into empty plates, respectively. Once the media 
had solidified, a metal borer was used to cut three wells into the agar. Aseptic technique 
was observed. All wells were filled for B0 spp. and BC spp. respectively. The plates were 
left upright and incubated for 16 hours. After incubation, the plates were removed for 
observation and measurement. The second objective of this experiment was to add a 
bioactive molecule, propolis, to potentially enhance or limit the effectiveness of 
competitive inhibition the Bacillus spp. could have on the SE species. The techniques 
used during this experiment were similar to those used in the first, but modified to 
potentially produce more viable results. The results did produce some evidence of 
competitive inhibition. As the search for healthier and more effective means of 
combating the presence of pathogenic microorganisms goes on, further research should 
be devoted towards probiotics and bioactive compounds. Probiotics serve as a natural 
competitor to pathogenic species and show signs of inhibitory success, as seen in this 
study. More research and experiments are required to support this evidence. As for 
bioactive compounds, specifically propolis, they have also become renowned for their 
antimicrobial activity. Results from this study suggest that the bioactive molecule 
propolis, in small concentrations, can be used as an additive to specific probiotic species 
to inhibit the growth of pathogenic species.  
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INTRODUCTION 
 
The use of antimicrobial drugs has come into question within the poultry industry 
in the United States due to an increased occurrence of antimicrobial resistant 
microorganisms. Evidence strongly suggests that the significant use of antibiotics has led 
to antimicrobial resistance (Levy and Marshall, 2004). Although this has not been 
proven, it has still has motivated the industry to explore new means of combating 
pathogenic microorganisms.  
One promising alternative approach to using antibiotics is the use of probiotics in 
poultry. There is a misconception, as some individuals only view microorganisms as 
germs. However, probiotics are microorganisms that possess no pathogenic 
characteristics or effects, and can potentially be utilized to inhibit the growth of microbial 
pathogenic species while also boosting metabolism of the host. In truth, microorganisms 
live on and in animal bodies and are often responsible for aiding food digestion, 
protection against pathogenic microorganisms, and producing vitamins (“Probiotics”, 
2017). There have been several microorganisms that have been identified as probiotics, 
which fall within these bacterial genera: Bacillus, Bifidobacterium, and Lactobacillus. 
Even though several species have been identified and researched extensively, the effects 
of each vary between them and still are not well understood (“Probiotics”, 2017). Further 
research into specific probiotic species and their effect on biological function is required.  
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In the last 4 years, the laboratory team has been researching strains of Bacillus 
bacteria isolated from sour dough (BO) and from the gastrointestinal tract of chickens 
(BC). Stock cultures from each source were submitted for sequencing according to the 
16s rRNA gene, which revealed many different strains. The identified BO and BC strains 
were subjected to several tests to determine resilience, which included: growth in an 
acidic medium (pH=3) and growth in 5% (M/V) Ox Bile/Luria-Bertani media. The 
strains that were resilient were then subjected to several tests that measured the activity of 
phytase, amylase, celluolytic activity, and protease. Strains from each source were 
selected for study in the laboratory’s research based on the amount of activity they had 
for each test. The BO strains selected were 3, 19, and 24, while the BC strains selected 
were 9, 12, and 21. A growth curve for the Bacillus species (spp.) was made and it was 
determined that the optimal growth occurred at 16 hours. The optimal growth occurs 
when the optical density equals the midpoint of the log phase in a growth curve. Also, the 
incubation temperature used in all experiments was 39
o
C because this is the internal 
temperature of poultry, which is commonly infected by pathogenic species. The 
pathogenic species chosen to be tested against in the laboratory’s experiments were 
Salmonella enterica serovar Muenchen (SE) and Shiga Toxin Producing Escherichia coli 
(EC). These species were chosen because they are associated pathogens to food safety 
and are very detrimental to the food industry. 
Another approach to not use antibiotics being investigated is the use of bioactive 
compounds as feed additives. These compounds are extra nutritional constituents found 
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in some foods, and have really become the focus of attention for their effects on health 
(Kris-Etherton, et al., 2002). Studies have been conducted to observe the effects of 
bioactive compounds, and it has been shown that they possess favorable effects. The 
most prominent effects of these compounds include antioxidant, antibacterial, and 
anticancer properties (Kris-Etherton, et al., 2002). 
 One such compound that possesses several bioactive components, and has 
demonstrated antioxidant and antibacterial properties is propolis. Propolis is a compound 
produced by honeybees to seal holes, fix structures in the beehive, and prevent the spread 
of microbial infections (Basim et al. 2006). The honeybees make propolis by collecting a 
brownish resinous material from tree leaf buds, bring the resin back to the hive, and 
modify it by mixing it with enzymes (beeswax) the bees secrete. The biological effects 
associated with propolis come from the plant resin component of the compound. Propolis 
has many beneficial biological effects, such as anti-inflammatory, antioxidant, or 
antibacterial, which has made it a longtime folk medicine remedy (Kim et al., 2008). The 
most prominent components of propolis responsible for its positive biological effects 
include aromatic acids, diterpenic acids, flavonoids, and phenolic compounds 
(Greenaway et al., 1991; Markham et al., 1996). One specific study found that propolis 
had a high concentration of phenolic compounds that showed a significant amount of 
biological activity. The study found that caffeic acid, ferulic acid, rutin, and p-coumaric 
acid were the most prominent phenolic compounds within propolis (Mohdaly et at., 
2015). This bioactive compound was chosen to be a bioactive additive for this experiment 
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not only because of its history as a well-known folk remedy, but also a member within 
the lab has a hobby of beekeeping, making it a special interest topic.  
The objectives of this study were to determine potential competitive inhibition 
between different strains of Bacillus spp. and pathogenic bacteria, and whether a 
bioactive molecule such as propolis would have an inhibitory effect. The experiments 
were designed to observe how effectively a probiotic (Bacillus spp.) might inhibit the 
growth of a pathogenic species, with or without the use of propolis. These experiments 
solely focused on microbiology aspects, rather than biochemical. This was meant to 
create preliminary data and create the basis for any future experiments regarding these 
potential probiotic Bacillus spp. and pathogens, as well the effects of the propolis 
bioactive compound. 
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METHODOLOGY 
 
The first objective of this experiment was to determine potential competitive inhibition 
between different strains of Bacillus spp. and pathogenic bacteria. The experiment was designed 
to observe how effectively a probiotic (Bacillus spp.) might inhibit the growth of a pathogenic 
species. The method used in the experiment was well diffusion, and can be observed in Figure 1. 
 
 
       
 
                                                          
 
Incubate 16 hrs 
Salmonella or 
E. coli 
Pipette 0.1% of the 
pathogen in regards to 
total volume of TSA 
TSA TSB 
BO3 BO3 
TSA/0.1% Salmonella plates 
100 μL of probiotic 
at known dilution 
Pour inoculated 
plates and cut wells 
into solidified media 
TSA/0.1% E. coli plates 
BO19 
BO24 
BO19 
BC21 
BC12 
BC9 
BC12 
BC9 
BO24 BC21 
Bacillus spp. 
 
A caliper is used to measure the 
diameter of the halo to measure the 
potential competitive inhibition.  
Figure 1: Flow chart of the well diffusion experimental procedures used for the first objective. 
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Pathogen species Salmonella enterica serovar Muenchen (SE) and Shiga Toxin-Producing 
Escherichia coli cultures were obtained from our collaborator Dr. Li Maria Ma, of Oklahoma 
State University. The pathogens were maintained as stock cultures. A single colony was isolated 
from streaked culture plates and then used to inoculate individual Tryptic Soy Agar (TSA) 
media. A specific volume was pipetted of each pathogen into their respective media so that they 
were 0.1% (V/V), which diluted the pathogens to 10
-3
 CFU/mL in TSA. The inoculated TSA 
media was then agitatedly incubated for 16 hours at 250 rpm and 39
o
C. The probiotic species 
were also cultivated, from isolated streak culture plates made from stock cultures kept in our lab, 
and incubated for 16 hours at 250 rpm and 39
o
C. After the pathogenic TSA had been incubated, 
they were immediately poured into empty plates, respectively. Once the media had solidified, a 
sterile cork borer was used to cut three wells into the agar. Aseptic technique was observed. 
When the wells were cut, 100 μL of one of the probiotic, in Tryptic Soy Broth (TSB) were 
pipetted into the well. All wells were filled for B0 spp. and BC spp. respectively. The plates were 
left upright and incubated for 16 hours at 39
o
C. After incubation, the plates were removed for 
observation and measurement. A caliper would be used to measure the diameter of the zone of 
inhibition.  
This first experiment that incorporated the undiluted samples of probiotics within the 
wells of the 0.1% (V/V) pathogenic TSA produced too much growth to adequately measure any 
possible zones of inhibition. This was a 1000:1 concentration ratio between the probiotics and 
pathogenic species. BC9 was the only exception because it produced zero growth. The probiotics 
that did demonstrate growth were large and grew very close to each other, limiting the ability to 
observe any competitive inhibition (halos surrounding the colony) between the Bacillus spp. and 
the pathogenic species.  In order to produce plates that would produce observable results 
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between the Bacillus spp. and the pathogens, it was determined that a smaller concentration ratio 
was needed. To start, a 1:1 concentration ratio was established by diluting the Bacillus spp. to 10
-
3
, while keeping the concentration of the pathogens constant at 10
-3
. The thought process was to 
start with 1:1 ratio, and then increase the concentration ratio by a factor of 10 until the 
concentration ratio of 1000:1 was reached. So, the Bacillus spp. were diluted to 10
-2
 and put 
through the same experiment to produce a concentration ratio of 10:1. Next, the Bacillus spp. 
were diluted to 10
-1
 to produce a concentration ratio of 100:1.  
The results of the first objective shaped the procedures for the second objective 
experiments. In the second objective, besides adding propolis to the incubating Bacillus spp. 
media, there would be several other changes to the procedure to produce consistent colony 
growth. These changes included: increasing the size of the incubated stock solution for all 
species from 10 mL to 50 mL tubes, not using a cork borer to cut the wells but rather pipetting a 
smaller volume on the top of the media, centrifuging the Bacillus strains to remove the 
supernatant and reconstitute the concentrated pellet in a smaller volume, and only using high 
concentrations of the Bacillus spp. in relation to the pathogen (>1000:1). Also, instead of testing 
six different Bacillus spp. and two different pathogens, it was determined that focusing on only 
three Bacillus spp. and one pathogen would be more manageable. The dilutions of both the 
probiotics and pathogen were also changed in an attempt to produce smaller singular colony 
growths rather than large prolific colonies. The BO species were diluted to 10
-3
 while the SE 
pathogen was diluted to 10
-9
, resulting in a concentration ratio of 10
6
:1.   
The second objective for this experiment was to add a bioactive molecule, propolis, to 
potentially enhance or limit the effectiveness of competitive inhibition the Bacillus spp. could 
have on the SE pathogen. The propolis used was an alcohol free extract at 30% concentration 
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(70% solvent) obtained through a vitamin supplement provider 
called eVitamins from Shelby Township, Michigan. It can be seen 
in Figure 2. The media was prepared first. 250 mL of TSB was 
mixed with 0.01% (V/V) propolis, boiled, and autoclaved. 250 
more mL of TSB was mixed with 0.1% (V/V) propolis, boiled, and 
autoclaved. Another 250 mL of TSB was mixed with 1.0% (V/V) 
propolis, boiled, and autoclaved. Then 250 mL of TSA was also 
mixed, boiled, and autoclaved. Next, both the BO Bacillus spp. and 
SE pathogen were cultivated and incubated for 16 hours at 250 rpm 
and 39
o
C. After the SE pathogen had finished incubating, it was diluted to 10
-6
 and then used to 
inoculate the 250 mL bottle of TSA by 0.1% (V/V), making the final concentration of pathogen 
10
-9
 CFU/mL. The SE pathogen inoculated TSA was then incubated in an agitation chamber for 
16 hours at 250 rpm and 39
o
C. After the BO Bacillus spp. had finished incubating, they were 
centrifuged for later re-suspension in the different propolis concentration TSB media. However, 
the centrifugation failed to form any pellets to which could be re-suspended. Therefore, a 10 mL 
tube of each propolis concentration for each BO species was prepared. The BO species were then 
vortexed, diluted to 10
-3
, and used to inoculate its respective propolis TSB tube, which made the 
final concentration of each Bacillus spp. 10
-3
 CFU/mL. The inoculated propolis TSB was 
incubated in an agitation chamber for 16 hours at 250 rpm and 39
o
C. Once the SE pathogen 
inoculated TSA had finished incubating, it was immediately poured into 9 petri plates. These 
plates were allowed to solidify and then were appropriately labeled. By this time, the BO species 
inoculated propolis TSB tubes had finished incubating and were removed from the agitation 
chamber. Then, 10 µL of each tube was pipetted onto the surface of the SE pathogen inoculated 
Figure 2: The propolis extract 
used for the experiments in the 
second objective.  
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TSA, respectively this was done three times. The interaction between the BO Bacillus spp. and 
the SE pathogen was at a concentration ration of 10
6
:1 (V/V). Placement of each aliquot was 
outlined on an empty plate as a reference, as seen in Figure 3. A 10 µL aliquot of the original   
10
-3
 BO species, which was not incubated in a propolis concentration, was also pipetted in the 
center of the plate to serve as a control. Once all the samples had been pipetted onto the plates, 
they were left upright and incubated for 16 hours at 39
o
C. After incubation, the plates were 
removed to be observed and measured if any zones of 
inhibition were present. This experiment was repeated 
in triplicate to determine if the results were repeatable.  
An additional experiment was conducted to 
demonstrate only the effects of propolis on the 
pathogenic media. This would serve as a negative 
control. Similarly to prior experiments, the media was   
prepared first. 250 mL of TSB was mixed with 0.01% 
(V/V) propolis, boiled, and autoclaved. 250 more mL of TSB was mixed with 0.1% (V/V) 
propolis, boiled, and autoclaved. Another 250 mL of TSB was mixed with 1.0% (V/V) propolis, 
boiled, and autoclaved. Then 250 mL of TSA was also mixed, boiled, and autoclaved. The SE 
pathogen were cultivated and incubated for 16 hours at 250 rpm and 39
o
C. After the SE pathogen 
had finished incubating, it was diluted to 10
-6
 and then used to inoculate the 250 mL bottle of 
TSA by 0.1% (V/V), making the final concentration of pathogen 10
-9
 CFU/mL. The SE pathogen 
inoculated TSA was then incubated in an agitation chamber for 16 hours at 250 rpm and 39
o
C. 
Once the SE pathogen inoculated TSA had finished incubating, it was immediately poured into 9 
petri plates. These plates were allowed to solidify and then were appropriately labeled. Then, 10 
Figure 3: Reference plate for placement of aliquots 
in the second objective experiments. 
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µL of each propolis TSB concentration was pipetted onto the surface of the SE pathogen 
inoculated TSA, respectively this was done three times. Placement of the aliquots was kept the 
same as the previous experiments, which can be seen in Figure 3. Once all the samples had been 
pipetted onto the plates, they were left upright and incubated for 16 hours at 39
o
C. After 
incubation, the plates were removed to be observed and measured if any zones of inhibition were 
present.
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RESULTS 
 
The following results are from the first objective, which only tested the 
interaction between the Bacillus spp. and the pathogens. The experiment that 
incorporated the undiluted samples of probiotics within the wells of the 0.1% (V/V) 
pathogenic TSA produced too much growth. This was a 1000:1 concentration ratio 
between the probiotics and pathogenic species. BC9 was the only exception because it 
produced zero growth. The probiotics that did demonstrate growth were large and grew 
very close to each other, limiting the ability to observe any type of competitive inhibition 
(halos surrounding the colony), as seen in Figure 4. The experiment that incorporated the 
probiotic samples that were diluted to 10
-3
 and put into the wells of the 0.1% (V/V) 
pathogenic TSA produced zero growth. This was a 1:1 concentration ratio between the 
probiotics and pathogenic species, as seen in Figure 5.  
             
                    
 
Figure 4: Results of the experiment of the first 
objective that had the concentration ratio of 
1000:1 (V/V) Bacillus/pathogen. 
Figure 5: Results of the experiment of the first 
objective that had the concentration ratio of 1:1 
(V/V) Bacillus/pathogen. 
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The experiment that incorporated the probiotic samples that were diluted to 10
-2
 and put 
into the wells of the 0.1% (V/V) pathogenic TSA produced zero growth. This was a 10:1 
concentration ratio between the probiotics and pathogenic species, as seen in Figure 6. 
The experiment that incorporated the probiotic samples that were diluted to 10
-1
 and put 
into the wells of the 0.1% (V/V) pathogenic TSA produced no halo of inhibition. This 
was a 100:1 concentration ratio between the probiotics and pathogenic species, as seen in 
Figure 7. 
             
 
  
The results from the experiments of the second objective show the interaction of 
several BO species incubated in varying concentrations of propolis TSB with a TSA 
medium inoculated with the SE pathogen. The specific placement of each BO species and 
propolis aliquot was outlined on an empty plate as a reference, as previously seen in 
Figure 3. The first experiment produced several plates that had singular colony growths. 
It is important to note that the SE pathogen inoculated medium appeared chunky and 
mottled with air bubbles. There was no growth of the 1.0% (V/V) BO3 or BO19, but 
growth was present for BO24. The growth for 0.1% (V/V) and 0.01% (V/V) BO species  
Figure 6: Results of the experiment of the first 
objective that had the concentration ratio of 
10:1 (V/V) Bacillus/pathogen. 
Figure 7: Results of the experiment of the 
first objective that had the concentration 
ratio of 100:1 (V/V) Bacillus/pathogen. 
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were present on all of the plates. Three different pictures of varying styles were taken of 
each plate to reveal any inhibitory effect not readily visible. The original pictures are in 
the left column, the pictures with a chrome filter are in the center column, and the black 
and white pictures in the far right column were taken with a Bio-Rad Imager. BO3 plates 
are on the top row, BO19 plates are in the second row, and BO24 plates are on the bottom 
row, as seen in Figure 8. 
 
 
  
 
 
 
Figure 8: Varying images of the plates of the first experiment to prove the objective of whether the 
addition of the bioactive compound propolis would enhance or inhibit the competitive inhibition the 
Bacillus spp. (10
-3
) could have on the SE species (10
-6
).  
 
Figure 8: Plates of the first experiment to prove the objective of whether the addition of the 
bioactive compound propolis would enhance or inhibit the competitive inhibition the Bacillus spp. 
(10
-3
) could have on the SE species (10
-6
). 
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These colonies were consistently large, singular colonies of growth. As for the control, 
there was zero growth on all of the plates.  
The second experiment produced plates that had overwhelming Bacillus growth. 
There were no isolated colonies on any of the plates, and therefore no distinction could be 
made between the different concentrations of propolis.  
 
 
 
 
 
Figure 9: Plates of the second experiment where Bacillus was able to grow without competition due to experimenter error 
preparing the TSA with the pathogen. The TSA had been overheated and then inoculated, which most probably resulted in 
the death of the pathogen. 
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Three different pictures of varying styles were taken of each plate to reveal any inhibitory 
effect not readily visible. The original pictures are in the left column, the pictures with a 
chrome filter are in the center column, and the black and white pictures in the far right 
column were taken with a Bio-Rad Imager. BO3 plates are on the top row, BO19 plates 
are in the second row, and BO24 plates are on the bottom row, as seen in Figure 9. 
The third experiment did result in observable occurrences of inhibition. There 
were colonies of growth for some BO species, zones of inhibition for a few species, and a 
lack of growth or inhibition for the rest. The areas of inhibition were hard to identify 
under normal light so the images taken were manipulated to produce more contrast for a 
sharper image, as seen in Figure 10. Three different pictures of varying styles were taken 
of each plate. In the left column, the pictures are manipulated with a “process” filter, the 
pictures in the middle column have a chrome filter, and the black and white pictures in 
the far right column were taken with a Bio-Rad Imager. BO3 plates are on the top row, 
BO19 plates are in the second row, and BO24 plates are on the bottom row. 
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The only zones of inhibition that were observed were on the BO3 plates. The most 
prominent of which were the 0.1% (V/V) and 0.01% (V/V) samples. There were some 
inhibition for 1.0% (V/V) and the control for BO3, but was minute and difficult to 
distinguish without using camera filters and the ImageJ software program (Rasband, 
2016). There was no evidence of inhibition for the rest of the samples on the remaining 
plates. The 1.0% (V/V) BO19 and BO24 samples did not produce any growth or 
Figure 10: Plates of the third experiment of the second objective, which demonstrated competitive inhibition. The 
images taken were manipulated to produce more contrast for a sharper image.  
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demonstrate inhibition. In Figure 10 it can be seen where the aliquots were placed 
because of a change in the refraction index of light. The 0.01% (V/V) and 0.1% (V/V) of 
both the BO19 and BO24 produced growth with no evidence of inhibition. As for the 
controls for both BO19 and BO24, there is only a small amount of observable growth and 
no evidence of an inhibition ring. The plates and specific aliquots that demonstrated 
competitive inhibition were measured for their area of inhibition, as seen in Table 1.  
 
Bacillus Species 
Propolis 
Concentration (%) 
Inhibition Zone Area 
(mm
2
) 
BO3 0 142 
BO3 0.01 155 
BO3 0.1 163 
BO3 1 36 
BO19 0 0 
BO19 0.01 0 
BO19 0.1 0 
BO19 1 0 
BO24 0 0 
BO24 0.01 0 
BO24 0.1 0 
BO24 1 0 
 
 As for the negative control experiment that only pipetted various concentrations 
of propolis onto the SE inoculated media, the plates did not produce results that were 
easy to observe. Without manipulating the photos with a chrome filter, as seen in Figure 
11, it is difficult to distinguish areas where aliquots were deposited. The chrome filtered 
photos show subtle areas of different color, which is where the varying concentrations of 
propolis were placed. Placement of the aliquots was kept the same as the previous 
Table 1: Inhibition zone areas of propolis concentrations and Bacillus spp. in 
the presence of Salmonella enterica serovar Muenchen media. 
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experiments, which can be seen in Figure 3. This can be attributed to the change of 
refraction index of light (identified with arrows), rather than any evidence of inhibition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Plates of the negative control experiment that only placed the varying propolis 
concentrations on the SE media.  The images taken were manipulated to produce more contrast for a 
sharper image. No inhibition was observed.  
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CONCLUSIONS 
 
The purpose for the first objective was to ascertain whether or not the Bacillus 
spp. would act as a probiotic and inhibit the growth of the pathogenic species. The 1000:1 
experiment was run first. As seen in Figure 3, the growth of the probiotic species was 
prolific and provided no concrete evidence of competitive inhibition between the 
probiotics and the pathogens. An interesting note to make is that in the presence of the 
pathogens, the probiotics demonstrated a competitive nature against each other. Serial 
dilutions were made of the probiotic species to lower the concentration ratio between the 
probiotics and pathogenic species. Beginning with the 1:1 ratio and moving back toward 
the 1000:1 ratio, we systematically worked through the concentration ratios to find the 
right one to which some form of controlled growth and signs of competitive inhibition 
could be observed. All the experiments run after the 1000:1 ratio produced no probiotic 
growth whatsoever, and thus no zones of inhibition. This was the case for all probiotics 
on both the Salmonella and E. coli media. Therefore, it is reasonable to conclude that 
Bacillus spp. are only capable of growth in the presence of pathogenic species when they 
outnumber the pathogen 1000:1. This conclusion seems reasonable because pathogenic 
microorganisms are very competitive and aggressive, which makes them such a problem 
within the food industry. Only a higher concentration of less competitive microorganisms 
would be able to compete with a pathogen. Also, the results of the experiments suggest 
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that these particular Bacillus spp. are not capable of inhibiting the growth of pathogenic 
species around them on their own, but rather demonstrate coexistence.  
The experiments of the first objective were run in triplicate to solidify the results, 
but they were done so at the same time on the same day. This was done this way because 
there were so many different strains and dilutions that each experiment took a very long 
time to complete. Therefore, instead of testing six different Bacillus spp. and two 
different pathogens, it was determined that focusing on only three Bacillus spp. and one 
pathogen would be more manageable. Also, it was in the best interest of our lab to run the 
experiments of the second objective on separate days, to ensure certainty within the 
results. In addition, the results of the first objective led us to make some procedural 
changes for the second objective to produce observable colonies. These changes 
included: increasing the volume of the incubated stock solution for all species from 10 
mL tubes to 50 mL tubes in order to increase the concentration in each sample, not using 
a cork borer to cut the wells but rather pipetting a smaller volume on the top of the media, 
and only using high concentrations of the Bacillus spp. compared to the pathogen 
(>1000:1). The decision to only use a concentration ratio greater than 1000:1 was 
determined directly from the results of the first objective, as only at this ratio Bacillus 
spp. growth was present. As for the discontinued use of the cut well technique, the 
amount that was pipetted into each well did not reach the top of the agar, dried during 
incubation, and thus made the Bacillus spp. responsible to grow up the walls of the well 
just to be observable. It was decided that no well would be cut and a smaller aliquot of 
the species would be pipetted on-top of the TSA.  
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The use of an additive with certain beneficial properties could be added to the 
probiotics to enhance any potential ability to inhibit the growth of pathogenic species, 
which became the second objective of this study. It was decided that the bioactive 
compound propolis would be added to the Bacillus spp. As mentioned previously in the 
introduction, propolis was chosen as the bioactive compound not only because of its long 
history as successful folk remedy, but also a member of the lab is a beekeeper in their 
spare time, making the study of propolis a special interest topic.  
The first experiment produced several plates that had singular colony growths that 
were large, yet discernable. In the results, it was mentioned that SE pathogen inoculated 
medium appeared chunky and was mottled with air bubbles. There was an unknown error 
in which the incubation of the pathogen inoculated TSA was disrupted, causing the TSA 
to partially solidify. Pouring partially solidified TSA is what gave the media its odd 
appearance. There was no growth of the 1.0% (V/V) BO3 or BO19, but growth was 
present for BO24. The growth for 0.1% (V/V) and 0.01% (V/V) BO species were present 
on all of the plates. These growths were large and their morphology clearly indicated that 
they were Bacillus spp. As for the controls, there was zero growth on all of the plates.  
Although there was an error in the incubation period of the SE inoculated TSA, it does 
not significantly affect the results of the experiment. Even though the SE pathogen was 
meant to be grown in liquefied agar, the nutrients would still be available to the pathogen 
if the agar was in a partial solid state. The SE pathogen was still present in the media, and 
the Bacillus spp. were able to compete for the nutrients in the agar. Evidence of 
coexistence was observed, rather than competitive inhibition.  
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As for the second experiment, it produced an overwhelming amount of Bacillus 
growth. There were no isolated colonies on any of the plates, and therefore no distinction 
could be made between the different concentrations of propolis. The results of this 
experiment are due to experimental error. During the process of making the TSA, the 
recently autoclaved bottle of TSA was placed in a water bath of 48
o
C to cool down 
overnight, as is all media after being autoclaved. The temperature of 48
o
C is used because 
it is not hot enough to kill the experimental microorganisms used in the lab, but is hot 
enough to keep the TSA in liquid form. The night the TSA bottle was stored in the water 
bath it was accidentally turned off, allowing the TSA to solidify. To rectify this, the TSA 
was heated in the lab microwave until it returned to its liquid state. At that point, it was 
immediately inoculated with the SE pathogen, which is where the error occurred. The 
TSA was too hot and most likely killed the SE pathogen, allowing the Bacillus aliquots 
later plated to grow without hindrance. Because the presence of the SE pathogen was 
lacking, the growth of the Bacillus spp. were too great to observe or measure any kind of 
inhibition. Although this experiment did not follow the methods outlined or produce the 
wanted results, it did serve as a control experiment. In the absence of the SE pathogen, 
Bacillus spp. with varying propolis concentrations were able to grow without hindrance. 
This reiterates the competitive nature that the SE pathogen possess.    
The third experiment produced results that suggested competitive inhibition. The 
apparent zones of inhibition were most prominent for 0.1% (V/V) and 0.01% (V/V) on 
the BO3 plate. There were some inhibition for 1.0% (V/V) and the control for BO3, but 
was minute and difficult to distinguish without using camera filters and the ImageJ 
software program. This program made it possible to measure the areas of the zones of 
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inhibition. There was no evidence of inhibition for the rest of the samples on the 
remaining plates. The 1.0% (V/V) BO19 and BO24 samples did not produce any growth 
or demonstrate inhibition. In Figure 10 it can be seen where the aliquots were placed 
because of a change in the refraction index of light. The 0.01% (V/V) and 0.1% (V/V) of 
both the BO19 and BO24 produced growth with no evidence of an inhibition ring. As for 
the controls for both BO19 and BO24, there is only a small amount of observable growth 
with no evidence of inhibition. The ImageJ program allowed us to measure the area of 
inhibition by measuring the total area of both the inhibition and cellular growth and 
subtracting the area of the cellular growth. The BO3 images of Figure 10 and the 
calculated areas of inhibition in Table 1 both indicate that the smaller concentrations of 
propolis with BO3 produced the largest areas of inhibition, while the large concentration 
of propolis with any of the Bacillus spp. produced small areas of inhibition, if any. In the 
case of the BO19 plate, although it did not show any concrete signs of competitive 
inhibition, the smaller concentrations of propolis allowed it to be competitive enough to 
coexist with the SE pathogen. This observation can also relate to the other plates as well, 
as the Bacillus aliquots of low concentration propolis grew larger, which some even had 
areas of inhibition, while the Bacillus aliquots with no propolis or a high concentration of 
propolis did not grow very well, or barely demonstrated any inhibition. It seems as 
though the Bacillus spp. responds well to the presence of propolis, but only up to a 
certain concentration.  
The additional experiment conducted to demonstrate only the effects of propolis 
on the pathogenic media served as a negative control for the Bacillus spp. Placements of 
the propolis aliquots could be observed due to the change of the refraction index of the 
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light. However, these results do not suggest that propolis alone inhibits the growth of the 
SE pathogen at these concentrations. Therefore, the areas of inhibition measured in the 
prior experiment were due to the synergistic effects of the propolis and Bacillus spp 
together.  
There are a couple of aspects to this study that should be investigated in further 
research. First, the propolis concentrations were mixed with the TSB media and then 
autoclaved, which could have altered the chemical compounds responsible for the activity 
associated with propolis. This heat treatment was unintended and has become a variable. 
In future research, the propolis should be added both before and after the media has been 
autoclaved to see if there is a significant difference in results. Second, a growth curve 
should be developed for each cultivation experiment to ensure consistency of growth 
conditions. The optimal incubating time of 16 hours was determined once, which will 
very between cultivations. Future studies should perform a growth curve experiment for 
each Bacillus spp. to provide consistency.   
As the search for healthier and more effective means of combating the presence of 
pathogenic microorganisms goes on, further research should be devoted towards 
probiotics and bioactive compounds. Probiotics serve as a natural competitor to 
pathogenic species and show signs of inhibitory success, as seen in this study. More 
research and experiments are required to support this evidence. As for bioactive 
compounds, specifically propolis, they have also become renowned for their 
antimicrobial activity. Results from this study suggest that the bioactive molecule 
propolis, in small concentrations, can be used as an additive to specific probiotic species 
to inhibit the growth of pathogenic species.  
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